Afimmune
Pre-clinicalAfimmune is a privately held drug discovery and development company focused on rare (Sickle Cell) and cardiometabolic diseases.
Founded
2015
Focus
Small Molecules
About
Afimmune is a privately held drug discovery and development company focused on rare (Sickle Cell) and cardiometabolic diseases.
Funding History
2Total raised: $12.5M
Grant$2.5MEuropean CommissionMar 15, 2020
Series A$10MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationDublin, Ireland
StagePre-clinical
Contact
SIMILAR COMPANIES
Remedy Biologics
Pre-clinical · Dublin
Aerogen
Pre-clinical · Galway
Bio Pharma Technical Consulting
Pre-clinical · Dublin
Astoriom
Pre-clinical · Dublin
Atlantia Clinical Trials
Pre-clinical · Cork
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile